高危型HPV与P16、Ki-67检测在宫颈癌早期筛查中的价值

Abstract
Figure/Table
References (15)
Related Citation (13)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the value of high-risk HPV,P16 and Ki-67 detection in early screening of cervical cancer.Methods From January 2015 to December 2017,30 cases of normal cervical tissue and the expression of P16 and Ki-67 in 75 cases of cervical intraepithelial neoplasia(CIN)were detected by immunohistochemistry in our hospital.The high-risk HPV infection was detected by polymerase chain reaction (PCR).Results The positivity rates of P16(77.80%)and Ki-67(65.80%)and In the CINⅠ,higher than those in normal cervical tissue accounting for 0.00%.The differences were statistically significant(P＜0.05).The positivity rates of P16(100.0%)and Ki-67(94.70%)in CINⅡ-Ⅲwas higher than those of CINⅠ (P＜0.05).High-risk HPV infection rates in normal cervical tissues,CINⅠ,and CIN Ⅱ-Ⅲwas 6.70%,66.70%,84.60%and 90.30%respectively,and the infection in the precancerous lesions the uterine cervix was significantly higher than that in the control group,the differences were statistically significant(P＜0.05).Conclusion High-risk HPV infection,P16,and Ki-67 are associated with the occurrence and development of precancerous lesions of the uterine cervix.Use in combination can be considered as an auxiliary method for the diagnosis of CIN grading and has a good application value.

Key words： Cervical precancerous lesion P16 Ki-67 High-risk HPV Immunohistochemistry

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Ke-hong
	LAI Jun-ling
	ZHANG Yuan-ping
	ZHANG Ying-jie
	WEN Da-xiong

Cite this article:

LI Ke-hong,LAI Jun-ling,ZHANG Yuan-ping, et al. The value of high-risk HPV，P16 and Ki-67 detection in early screening of cervical cancer[J]. 中国当代医药, 2018, 25(14): 60-62.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I14/60

[1]	Lee H.Special issue on globalh health disparities focus on cancer[J].Asia Pac J Oncol Nurs，2016，3（4）：309-311.
[2]	Prasonqvei P，Nanthakomon T，Jaisin K，et al.Quality of life in cervical cancer survivors and healthy woman：thai urban population study[J].Asian Pac J Cancer Prev，2017，18（2）：385-389.
[3]	李永川，徐含青，赵娜，等.重庆地区32882例女性宫颈人乳头瘤病毒的感染情况调查[J].第三军医大学学报，2016，38（9）：1031-1034.
[4]	Wheeler CM.The natural history of cervical human papillomavirus infections and cervical cancer：gaps in knowledge and future horizons[J].Obstet Gynecol Clin North Am，2013，40（2）：165-176.
[5]	左玲，李顺英，邓亭月.TCT联合高危型HPV检测在社区宫颈癌筛查中的应用价值[J].海南医学，2016，27（10）：1628-1630.
[6]	Vaidakis D，Moustaki I，Zervas I，et al.Knowledge of Greek adolescents on human papilloma virus（HPV） and vaccination： A national epidemiologic study[J].Medicine（Baltimore），2017，96（1）：e5287.
[7]	周莉，孔敏，李海霞，等.P16在宫颈癌组织中的表达及临床意义[J].中国实验诊断学，2013，17（9）：1614-1616.
[8]	COX JT.Human Papillomavirus testing in pimay cervical screening and abnormal papanicolaou management[J].Obstet Gynecol Surv，2006，61（6 Suppl 1）：815-825.
[9]	Koc N，Sahin D，Ayas S.Reevaluation of negative cone biopsy results after a positive cervical biopsy fingding[J].J Low Genit Tract Dis，2013，17（2）：154-159.
[10]	陈海霞，刘爱云，时念学，等.宫颈鳞状上皮病变组织中乳头状瘤病毒和Ki-67及p16INK4a蛋白表达意义的研究[J].中华肿瘤防治杂志，2009，16（22）：1786-1788.
[11]	杭国红.薄层液基细胞学检查、高危型HPV-DNA检测联合宫颈脱落细胞p16蛋白检测在宫颈癌早期筛查中的价值[J].中国妇幼保健，2017，32（22）：5569-5571.
[12]	赫芳芳，高英，魏力.p16、Ki-67在宫颈鳞状上皮病变分级诊断中的意义[J].现代肿瘤医学，2016，24（8）：1271-1274.
[13]	陈娇，孔为民.宫颈癌筛查方法的现状与研究进展[J].医学综述，2016，22（12）：2338-2342.
[14]	陆晓青，陈洁瑛，舒青青，等.宫颈液基薄层脱落细胞联合HPV及p16检测在宫颈癌早期筛查中的临床意义[J].浙江医学，2014，36（13）：1147-1149.
[15]	叶洪楠，游珂，郭艳利，等.P16～（INK4a）及 Ki-67 免疫细胞化学检测对ASC-US中高级别病变检出的意义[J].肿瘤预防与治疗，2014，27（1）：6-11.